Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04413578 · ClinicalTrials.gov registry record · Phase 4
CGM - Reimagine Primary Care
A Phase 4 study, sponsored by Intermountain Health Care.
- Completed
- Registry status
- Phase 4
- Development phase
- 101
- Enrollment target
NCT04413578 is a Phase 4 study that has completed, run by Intermountain Health Care. The registered enrollment target is 101 participants.
The verdict
NCT04413578, a Phase 4 study, has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 101 participants
- Enrollment target
Study Summary
To assess the impact of continuous glucose monitoring versus standard of care (e.g. a finger-prick protocol using a glucometer) on clinical outcomes, healthcare utilization, and cost in patients with type I or II diabetes treated within the Reimagine Primary Care clinics.
Interventions
- DEVICE Dexcom G6
- DEVICE Contour NextOne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2018-12-01 |
| Est. Completion | 2019-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04413578
The ClinicalTrials.gov registry entry for NCT04413578 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexcom G6 is the first listed.
NCT04413578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04413578 about?
NCT04413578 is a clinical study titled "CGM - Reimagine Primary Care". To assess the impact of continuous glucose monitoring versus standard of care (e.g. a finger-prick protocol using a glucometer) on clinical outcomes, healthcare utilization, and cost in patients with type I or II diabetes treated within the Reimagine Primary Care clinics.
What is the current status of trial NCT04413578?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 101 participants. The study started on 2018-12-01. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT04413578?
The interventions under investigation include: Dexcom G6 (DEVICE), Contour NextOne (DEVICE).
Who is sponsoring clinical trial NCT04413578?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.